practolol has been researched along with Dermatitis Medicamentosa in 37 studies
Practolol: A beta-1 adrenergic antagonist that has been used in the emergency treatment of CARDIAC ARRYTHMIAS.
practolol : N-(4-Hydroxyphenyl)acetamide in which the hydrogen of the phenolic hydroxy group is substituted by a 3-(isopropylaminoamino)-2-hydroxypropyl group. A selective beta blocker, it has been used in the emergency treatment of cardiac arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The clinical distribution of an antibody to a metabolite of practolol was investigated, particularly in relation to the oculomucocutaneous syndrome." | 7.66 | Possible role of antibody specific for a practolol metabolite in the pathogenesis of oculomucocutaneous syndrome. ( Amos, HE; Artis, J; Lake, BG, 1978) |
| "Practolol ('Eraldin') is a beta-blocking agent whose prolonged use may result in the appearance of untoward side-effects, notably ocular symptoms, skin rashes and deafness." | 7.65 | Practolol and deafness. ( Ballantyne, JC; Hammond, VT; Jones, RF; Wright, D, 1977) |
| "Practolol is a cardio-selective beta-blocking agent with an intrinsic sympathomimetic action, but devoid of local anaesthetic effect." | 6.64 | Practolol in acute myocardial infarction. ( Barber, JM; Boyle, DM; Chaturvedi, NC; Singh, N; Walsh, MJ, 1976) |
| "Practolol was found to aggravate existing psoriasis in 3 patients and render it extremely refractory to therapy." | 5.26 | Aggravation of psoriasis and occurrence of psoriasiform cutaneous eruptions induced by practolol (Eraldin). ( Jensen, HA; Mikkelsen, HI; Sondergaard, J; Wadskov, S, 1976) |
| "The clinical distribution of an antibody to a metabolite of practolol was investigated, particularly in relation to the oculomucocutaneous syndrome." | 3.66 | Possible role of antibody specific for a practolol metabolite in the pathogenesis of oculomucocutaneous syndrome. ( Amos, HE; Artis, J; Lake, BG, 1978) |
| "Recognition of the "occulomucocutaneous syndrome" related to practolol administration has caused the safety of other beta-blocking agents to come under close scrutiny." | 3.65 | Practolol and the safety of other beta blockers. ( Sutherland, DC; Wilson, JD, 1976) |
| "Practolol ('Eraldin') is a beta-blocking agent whose prolonged use may result in the appearance of untoward side-effects, notably ocular symptoms, skin rashes and deafness." | 3.65 | Practolol and deafness. ( Ballantyne, JC; Hammond, VT; Jones, RF; Wright, D, 1977) |
| "Practolol is a cardio-selective beta-blocking agent with an intrinsic sympathomimetic action, but devoid of local anaesthetic effect." | 2.64 | Practolol in acute myocardial infarction. ( Barber, JM; Boyle, DM; Chaturvedi, NC; Singh, N; Walsh, MJ, 1976) |
| "The possible adverse effects of treatment during pregnancy are also considered." | 2.36 | Beta-adrenoceptor blocking drugs: adverse reactions and drug interactions. ( Beeley, L; Kendall, MJ, 1983) |
| "Practolol has been linked with a lupus syndrome characterized by biological abnormalities and eventually clinical signs; later on, other beta-blocking agents have been able to induce such manifestations." | 1.26 | [Review: beta-blocking agents in dermatology (author's transl)]. ( Bourlond, A; Clerens, A; Defresne, C; Guilmot-Bruneau, MM, 1981) |
| "Practolol was found to aggravate existing psoriasis in 3 patients and render it extremely refractory to therapy." | 1.26 | Aggravation of psoriasis and occurrence of psoriasiform cutaneous eruptions induced by practolol (Eraldin). ( Jensen, HA; Mikkelsen, HI; Sondergaard, J; Wadskov, S, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 37 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clerens, A | 1 |
| Guilmot-Bruneau, MM | 1 |
| Defresne, C | 1 |
| Bourlond, A | 1 |
| Kendall, MJ | 1 |
| Beeley, L | 1 |
| Bonnetblanc, JM | 1 |
| McQueen, A | 2 |
| Behan, WM | 2 |
| Erikssen, J | 1 |
| Sutherland, DC | 1 |
| Wilson, JD | 1 |
| Frishman, W | 1 |
| Silverman, R | 1 |
| Strom, J | 1 |
| Elkayam, U | 1 |
| Sonnenblick, E | 1 |
| Mobacken, H | 1 |
| Faure, M | 1 |
| Hermier, C | 1 |
| Perrot, H | 1 |
| van der Meer, J | 1 |
| Wadskov, S | 2 |
| Sondergaard, J | 2 |
| Svejgaard, A | 1 |
| Mikkelsen, HI | 2 |
| Jensen, HA | 2 |
| Behan, PO | 1 |
| Zacharias, FJ | 1 |
| Nicholls, JT | 2 |
| Scott, DF | 1 |
| Williams, P | 1 |
| Byrn, E | 1 |
| Reersted, P | 1 |
| Holt, PJ | 1 |
| Waddington, E | 1 |
| Brinck, HP | 1 |
| Aasved, H | 1 |
| Jacobsen, KB | 1 |
| Mackie, RM | 1 |
| Milne, JA | 1 |
| Dunn, PJ | 1 |
| Faber, WR | 1 |
| Hulsebosch, HJ | 1 |
| Overdijk, AD | 1 |
| van der Upwich, WG | 1 |
| Barber, JM | 1 |
| Boyle, DM | 1 |
| Chaturvedi, NC | 1 |
| Singh, N | 1 |
| Walsh, MJ | 1 |
| Cochran, RE | 1 |
| Thomson, J | 1 |
| Fleming, K | 1 |
| Sneddon, IB | 1 |
| Kauppinen, K | 2 |
| Niemi, KM | 2 |
| Salo, OP | 2 |
| Ahonen, A | 1 |
| Jachuck, SJ | 1 |
| Stephenson, J | 1 |
| Bird, T | 1 |
| Jackson, FS | 1 |
| Clark, F | 1 |
| Jones, RF | 1 |
| Hammond, VT | 1 |
| Wright, D | 1 |
| Ballantyne, JC | 1 |
| Amos, HE | 1 |
| Lake, BG | 1 |
| Artis, J | 1 |
| Dring, LG | 1 |
| Gorchein, A | 1 |
| Mahgoub, AA | 1 |
| Smith, RL | 1 |
| van Joost, T | 1 |
| Felix, R | 1 |
| Ive, FA | 2 |
| Wright, P | 1 |
| Felix, RH | 1 |
| Dahl, MG | 1 |
| Proctor, CR | 1 |
3 reviews available for practolol and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Beta-adrenoceptor blocking drugs: adverse reactions and drug interactions.
Topics: Adrenergic beta-Antagonists; Bradycardia; Brain; Drug Eruptions; Drug Interactions; Eye Diseases; Fe | 1983 |
Perspectives in dermatology: Great Britain (1972-1974).
Topics: Aging; Animals; Dermatitis Herpetiformis; Dermatology; Drug Eruptions; Freeze Fracturing; Humans; Im | 1975 |
The clinical aspects of drugs and disease of the skin.
Topics: Contraceptives, Oral, Hormonal; Drug Eruptions; Erythema Nodosum; Food Preservatives; Humans; Lichen | 1975 |
2 trials available for practolol and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Practolol in acute myocardial infarction.
Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Constipation; Drug Eruptions; Female; Humans; | 1976 |
Practolol-induced autoantibodies and their relation to oculo-cutaneous complications.
Topics: Adult; Aged; Autoantibodies; Clinical Trials as Topic; Coronary Disease; Drug Eruptions; Eye Disease | 1977 |
32 other studies available for practolol and Dermatitis Medicamentosa
| Article | Year |
|---|---|
[Review: beta-blocking agents in dermatology (author's transl)].
Topics: Adrenergic beta-Antagonists; Drug Eruptions; Humans; Practolol | 1981 |
[Drug eruptions caused by beta-blockers].
Topics: Adrenergic beta-Antagonists; Drug Eruptions; Humans; Practolol; Skin Diseases | 1984 |
Immunofluorescence microscopy. The "string of Pearls" phenomenon-an immunofluorescent serological finding in patients screened for adverse drug reactions.
Topics: Animals; Arthritis, Rheumatoid; Autoantibodies; Dermatomyositis; Drug Eruptions; Epidermis; Esophagu | 1982 |
[Oculocutaneous reactions following treatment with betablockers].
Topics: Adrenergic beta-Antagonists; Drug Eruptions; Eye Diseases; Humans; Practolol | 1976 |
Practolol and the safety of other beta blockers.
Topics: Adrenergic beta-Antagonists; Aged; Antibodies, Antinuclear; Drug Eruptions; Eye Diseases; Female; Hu | 1976 |
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Bronchi; Central Nervous System Diseases; Deafnes | 1979 |
Cutaneous side effects from beta-blockers and other antihypertensive agents.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Drug Eruptions; Humans; Practolol | 1979 |
[Cutaneous reactions to propranolol (author's transl)].
Topics: Adolescent; Adrenergic beta-Antagonists; Antibodies, Antinuclear; Drug Eruptions; Eczema; Humans; Lu | 1979 |
[Practolol (Eraldin)].
Topics: Antibodies, Antinuclear; Arrhythmias, Cardiac; Deafness; Drug Eruptions; Humans; Keratoconjunctiviti | 1975 |
HL-A histocompatibility antigens and cutaneous reactions to practolol.
Topics: Adult; Aged; Drug Eruptions; Female; Histocompatibility Antigens; HLA Antigens; Humans; Middle Aged; | 1976 |
Aggravation of psoriasis and occurrence of psoriasiform cutaneous eruptions induced by practolol (Eraldin).
Topics: Adult; Aged; Drug Eruptions; Female; Humans; Keratoconjunctivitis; Male; Middle Aged; Practolol; Pso | 1976 |
Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy.
Topics: Adult; Aged; Autoantibodies; Autoimmune Diseases; Coronary Disease; Drug Eruptions; Eye Diseases; Fe | 1976 |
Letter: Skin rash, conjunctivitis and plastic peritonitis with practolol therapy.
Topics: Conjunctivitis; Drug Eruptions; Humans; Male; Middle Aged; Peritonitis; Practolol; Psoriasis | 1975 |
[Actual late effects. Skin, eye and hearing changes during treatment with practolol (Eraldin)].
Topics: Drug Eruptions; Eye Diseases; Hearing Disorders; Humans; Practolol | 1975 |
[Conjunctivitis, stomatitis, glossitis, otitis and psoriasiform skin diseases during long-term treatment with practolol (Eraldin)].
Topics: Aged; Conjunctivitis; Dose-Response Relationship, Drug; Drug Eruptions; Female; Glossitis; Humans; O | 1975 |
Oculocutaneous reaction to oxprenolol.
Topics: Aged; Biopsy; Drug Eruptions; Eye Diseases; Heart Diseases; Humans; Oxprenolol; Practolol | 1975 |
[Complications in treatment with beta blockader Practolol (Eraldin)].
Topics: Drug Eruptions; Humans; Keratoconjunctivitis; Male; Middle Aged; Practolol | 1975 |
Sjogren's syndrome and drug reaction to practalol.
Topics: Aged; Corneal Ulcer; Dermatitis, Exfoliative; Drug Eruptions; Humans; Male; Practolol; Sjogren's Syn | 1975 |
[A patient with skin eruptions due to practolol].
Topics: Aged; Drug Eruptions; Erythema; Female; Humans; Keratosis; Pigmentation Disorders; Practolol | 1976 |
The psoriasiform eruption induced by practolol.
Topics: Aged; Angina Pectoris; Atrial Fibrillation; Drug Eruptions; Female; Humans; Male; Middle Aged; Pract | 1975 |
Letter: Dermatosis induced by practolol.
Topics: Drug Eruptions; Humans; Practolol | 1976 |
Adverse effects of practolol.
Topics: Drug Eruptions; Drug Evaluation; Eye Diseases; Humans; Practolol | 1976 |
Cutaneous reactions to practolol. Clinical and histopathological study.
Topics: Administration, Oral; Aged; Dose-Response Relationship, Drug; Drug Eruptions; Eye Diseases; Female; | 1976 |
[Adverse effects of practolol].
Topics: Drug Eruptions; Eye Diseases; Humans; Practolol | 1976 |
Practolol and deafness.
Topics: Aged; Conjunctivitis; Deafness; Drug Eruptions; Female; Humans; Male; Middle Aged; Practolol | 1977 |
Possible role of antibody specific for a practolol metabolite in the pathogenesis of oculomucocutaneous syndrome.
Topics: Antibodies; Antibody Specificity; Drug Eruptions; Eye Diseases; Humans; Mucous Membrane; Practolol; | 1978 |
The elimination of practolol by two human subjects.
Topics: Drug Eruptions; Female; Humans; Male; Middle Aged; Practolol; Radioisotope Dilution Technique; Time | 1978 |
[Is this psoriasis vulgaris?].
Topics: Aged; Dermatitis, Contact; Diagnosis, Differential; Drug Eruptions; Female; Hand Dermatoses; Humans; | 1979 |
Letter: Skin reactions to practolol.
Topics: Drug Eruptions; Humans; Practolol; Psoriasis | 1974 |
Letter: Skin reactions to practolol.
Topics: Drug Eruptions; Eye Diseases; Humans; Practolol | 1974 |
Cutaneous and ocular reactions to practolol.
Topics: Aged; Biopsy; Corneal Ulcer; Drug Eruptions; Ectropion; Facial Dermatoses; Female; Fluorescent Antib | 1974 |
Letter: Report on adverse reactions associated with practolol.
Topics: Drug Eruptions; Eye Diseases; Hearing Disorders; Humans; Pericarditis; Peritonitis; Practolol | 1974 |